Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (241-250 of 347) with videos related to

Pageof 35
Sort By:
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2024
Expression of L1 Cell Adhesion Molecule, a Nephronal Principal Cell Marker, in Nephrogenic AdenomaRahul Mannan, Xiaoming Wang, Somnath Mahapatra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy responseYuping Zhang, Sathiya P Narayanan, Rahul Mannan, et al.
Neoplasia (New York, N.Y.)|February 3, 2025
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastomaSeema Chugh, Jean C Tien, Jennifer Hon, et al.
Neoplasia (New York, N.Y.)|July 24, 2010
Antibody-based detection of ERG rearrangement-positive prostate cancerKyung Park, Scott A Tomlins, Kumaran M Mudaliar, et al.
Urology|August 11, 2020
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic PracticeAmir H Lebastchi, Christopher M Russell, Yashar S Niknafs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2015
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasHarrison Tsai, Carlos L Morais, Mohammed Alshalalfa, et al.
The American Journal of Surgical Pathology|April 29, 2026
International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the KidneySean R Williamson, Sara E Wobker, Rohit Mehra, et al.
Pageof 35

Showing results (241-250 of 347) with videos related to

Sort By:
Pageof 35
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2024
Expression of L1 Cell Adhesion Molecule, a Nephronal Principal Cell Marker, in Nephrogenic AdenomaRahul Mannan, Xiaoming Wang, Somnath Mahapatra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy responseYuping Zhang, Sathiya P Narayanan, Rahul Mannan, et al.
Neoplasia (New York, N.Y.)|February 3, 2025
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastomaSeema Chugh, Jean C Tien, Jennifer Hon, et al.
Neoplasia (New York, N.Y.)|July 24, 2010
Antibody-based detection of ERG rearrangement-positive prostate cancerKyung Park, Scott A Tomlins, Kumaran M Mudaliar, et al.
Urology|August 11, 2020
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic PracticeAmir H Lebastchi, Christopher M Russell, Yashar S Niknafs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2015
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasHarrison Tsai, Carlos L Morais, Mohammed Alshalalfa, et al.
The American Journal of Surgical Pathology|April 29, 2026
International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the KidneySean R Williamson, Sara E Wobker, Rohit Mehra, et al.
Pageof 35